Dedicare Past Earnings Performance
Past criteria checks 3/6
Dedicare has been growing earnings at an average annual rate of 31.5%, while the Healthcare industry saw earnings declining at 0.9% annually. Revenues have been growing at an average rate of 23.3% per year. Dedicare's return on equity is 29.6%, and it has net margins of 5.1%.
Key information
31.5%
Earnings growth rate
30.6%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 23.3% |
| Return on equity | 29.6% |
| Net Margin | 5.1% |
| Next Earnings Update | 12 Jul 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Dedicare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 1,900 | 96 | 200 | 0 |
| 31 Dec 23 | 1,973 | 110 | 200 | 0 |
| 30 Sep 23 | 2,011 | 102 | 28 | 0 |
| 30 Jun 23 | 1,937 | 102 | 24 | 0 |
| 31 Mar 23 | 1,882 | 105 | 140 | 0 |
| 31 Dec 22 | 1,772 | 101 | 180 | 0 |
| 30 Sep 22 | 1,623 | 93 | 55 | 0 |
| 30 Jun 22 | 1,504 | 84 | 36 | 0 |
| 31 Mar 22 | 1,379 | 76 | 18 | 0 |
| 31 Dec 21 | 1,250 | 66 | 0 | 0 |
| 30 Sep 21 | 1,143 | 61 | 139 | 0 |
| 30 Jun 21 | 1,063 | 55 | 114 | 0 |
| 31 Mar 21 | 980 | 42 | 92 | 0 |
| 31 Dec 20 | 885 | 36 | 70 | 0 |
| 30 Sep 20 | 823 | 29 | 62 | 0 |
| 30 Jun 20 | 783 | 23 | 62 | 0 |
| 31 Mar 20 | 762 | 26 | 62 | 0 |
| 31 Dec 19 | 776 | 26 | 62 | 0 |
| 30 Sep 19 | 784 | 28 | 65 | 0 |
| 30 Jun 19 | 794 | 31 | 65 | 0 |
| 31 Mar 19 | 803 | 32 | 65 | 0 |
| 31 Dec 18 | 812 | 38 | 65 | 0 |
| 30 Sep 18 | 812 | 42 | 61 | 0 |
| 30 Jun 18 | 787 | 43 | 61 | 0 |
| 31 Mar 18 | 778 | 50 | 61 | 0 |
| 31 Dec 17 | 785 | 60 | 61 | 0 |
| 30 Sep 17 | 781 | 68 | 53 | 0 |
| 30 Jun 17 | 759 | 72 | 53 | 0 |
| 31 Mar 17 | 716 | 65 | 53 | 0 |
| 31 Dec 16 | 650 | 53 | 53 | 0 |
| 30 Sep 16 | 603 | 42 | 149 | 0 |
| 30 Jun 16 | 585 | 33 | 149 | 0 |
| 31 Mar 16 | 573 | 30 | 149 | 0 |
| 31 Dec 15 | 573 | 30 | 149 | 0 |
| 30 Sep 15 | 567 | 31 | 0 | 0 |
| 30 Jun 15 | 548 | 31 | 0 | 0 |
| 31 Mar 15 | 523 | 28 | 0 | 0 |
| 31 Dec 14 | 498 | 23 | 0 | 0 |
| 30 Sep 14 | 482 | 17 | 0 | 0 |
| 30 Jun 14 | 468 | 14 | 0 | 0 |
| 31 Mar 14 | 467 | 13 | 0 | 0 |
| 31 Dec 13 | 469 | 14 | 0 | 0 |
| 30 Sep 13 | 486 | 15 | 1 | 0 |
| 30 Jun 13 | 507 | 17 | 1 | 0 |
Quality Earnings: CL6 has high quality earnings.
Growing Profit Margin: CL6's current net profit margins (5.1%) are lower than last year (5.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CL6's earnings have grown significantly by 31.5% per year over the past 5 years.
Accelerating Growth: CL6's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CL6 had negative earnings growth (-8.4%) over the past year, making it difficult to compare to the Healthcare industry average (-2.2%).
Return on Equity
High ROE: CL6's Return on Equity (29.6%) is considered high.